Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Resusc Plus ; 18: 100623, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38590448

RESUMEN

Introduction: Out of hospital cardiac arrest (OHCA) remains one of the main causes of death among industrialized countries. The initiation of cardiopulmonary resuscitation (CPR) by laypeople before the arrival of emergency medical services improves survival. Mouth-to-mouth ventilation may constitute a hindering factor to start bystander CPR, while during continuous chest compressions (CCC) CPR quality decreases rapidly. The aim of this scoping review is to examine the existing literature on strategies that investigate the inclusion of intentional pauses during compression-only resuscitation (CO-CPR) to improve the performance in the context of single lay rescuer OHCA. Methods: The protocol of this Scoping review was prospectively registered in Open Science Framework (https://osf.io/rvn8j). A systematic search of PubMed, Scopus, EMBASE, CINAHL was performed. Results: Six articles were included. All studies were carried out on simulation manikins and involved a total of 1214 subjects. One study had a multicenter design. Three studies were randomized controlled simulation trials, the rest were prospective randomized crossover studies. The tested protocols were heterogeneous and compared CCC to CO-CPR with intentional interruptions of various length. The most common primary outcome was compressions depth. Compression rate, rescuers' perceived exertion and composite outcomes were also evaluated. Compressions depth and perceived exertion improved in most study groups while compression rate and chest compression fraction remained within guidelines indications. Conclusions: In simulation studies, the inclusion of intentional interruptions during CO-CPR within the specific scenario of single rescuer bystander CPR during OHCA may improve the rate of compressions with correct depth and lower rate of perceived exertion. Further high-quality research and feasibility and safety of protocols incorporating intentional interruptions during CO-CPR may be justified.

2.
Healthcare (Basel) ; 11(5)2023 Feb 24.
Artículo en Inglés | MEDLINE | ID: mdl-36900674

RESUMEN

BACKGROUND: During COVID-19 pandemic, restrictions to in-person visiting of caregivers to patients admitted to intensive care units (ICU) were applied in many countries. Our aim was to describe the variations in communication and family visiting policies in Italian ICUs during the pandemic. METHODS: A secondary analysis from the COVISIT international survey was conducted, focusing on data from Italy. RESULTS: Italian ICUs provided 118 (18%) responses out of 667 responses collected worldwide. A total of 12 Italian ICUs were at the peak of COVID-19 admissions at the time of the survey and 42/118 had 90% or more of patients admitted to ICU affected by COVID-19. During the COVID-19 peak, 74% of Italian ICUs adopted a no-in-person-visiting policy. This remained the most common strategy (67%) at the time of the survey. Information to families was provided by regular phone calls (81% in Italy versus 47% for the rest of the world). Virtual visiting was available for 69% and most commonly performed using devices provided by the ICU (71% in Italy versus 36% outside Italy). CONCLUSION: Our study showed that restrictions to the ICU applied during the COVID-19 pandemic were still in use at the time of the survey. The main means of communication with caregivers were telephone and virtual meetings.

3.
Clin Case Rep ; 10(12): e6805, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36590666

RESUMEN

We report a case of out-of-hospital cardiac arrest occurred in a 61-year-old recreational female diver. After resuscitation, the patient was referred to the hospital. With data provided by witnesses and appropriate medical investigations, drowning related to a failed rebreather system was the most plausible explanation. Patient outcome was favorable.

4.
Microorganisms ; 9(10)2021 Sep 23.
Artículo en Inglés | MEDLINE | ID: mdl-34683337

RESUMEN

BACKGROUND: Little is known about the occurrence of bloodstream infections in hospitalized patients with COVID-19 and the related clinical consequences. The aim of this systematic review and meta-analysis was to estimate the pooled occurrence of BSIs among hospitalized patients with COVID-19 and mortality of this patient population. METHODS: A systematic search was performed on PubMed, EMBASE, and Web of Science from inception to 19 April 2021. The primary outcome was the occurrence of BSIs among hospitalized patients with COVID-19. The secondary outcome was mortality at the longest available follow-up. RESULTS: Forty-six studies met the inclusion criteria, with a total of 42,694 patients evaluated. The estimated occurrence of BSIs was 7.3% (95% CI 4.7-1.1%) among hospitalized patients with COVID-19, with a mortality rate of 41% (95% CI 30%-52.8%). The subgroup analysis conducted on patients admitted to ICU provided an estimated occurrence of 29.6% (95% CI 21.7%-38.8%). A higher occurrence of BSI was observed in patients with COVID-19, in comparison with patients without COVID-19 (OR 2.77; 95% CI 1.53-5.02; p < 0.001). CONCLUSIONS: Our analysis estimated the occurrence of BSIs among hospitalized patients with COVID-19 at around 7%. A four-times higher occurrence was estimated among patients admitted to ICU.

5.
J Mol Cell Cardiol ; 51(5): 777-80, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21798264

RESUMEN

Heat shock protein 60 (HSP60), expressed on the surface of endothelial cells (ECs) stressed by e.g. oxidized LDL or mechanical shear, was shown to function as an auto-antigen and thus as a pro-atherosclerotic molecule. The aim of this study was to determine whether cigarette smoke chemicals can lead to the activation of the "HSP60 pathway." It was also our aim to elucidate the dynamics of HSP60 from gene expression to endothelial surface expression and secretion. Here we show for the first time that the exposure of human umbilical vein endothelial cells (HUVECs) to cigarette smoke extract (CSE) results in an up-regulation of HSP60 mRNA. Live cell imaging analysis of a HSP60-EYFP fusion protein construct transfected into ECs revealed that mitochondrial structures collapse in response to CSE exposure. As a result, HSP60 is released from the mitochondria, transported to the cell surface, and released into the cell culture supernatant. Analysis of HSP60 in the sera of healthy young individuals exposed to secondhand smoke revealed significantly elevated levels of HSP60. Cigarette smoking is one of the most relevant risk factors for atherosclerosis. Herein, we provide evidence that cigarette smoke may initiate atherosclerosis in the sense of the "auto-immune hypothesis of atherosclerosis."


Asunto(s)
Chaperonina 60 , Células Endoteliales de la Vena Umbilical Humana/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Nicotiana/efectos adversos , Proteínas Recombinantes de Fusión , Humo/efectos adversos , Fumar/efectos adversos , Antioxidantes/farmacología , Aterosclerosis/sangre , Aterosclerosis/etiología , Aterosclerosis/fisiopatología , Autoinmunidad/efectos de los fármacos , Células Cultivadas , Chaperonina 60/biosíntesis , Chaperonina 60/genética , Chaperonina 60/inmunología , Chaperonina 60/metabolismo , Mezclas Complejas/efectos adversos , Expresión Génica , Células Endoteliales de la Vena Umbilical Humana/citología , Células Endoteliales de la Vena Umbilical Humana/inmunología , Humanos , Microscopía , Mitocondrias/genética , Mitocondrias/metabolismo , Mitocondrias/ultraestructura , Plásmidos , Transporte de Proteínas , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/inmunología , Proteínas Recombinantes de Fusión/metabolismo , Fumar/sangre , Transfección , Regulación hacia Arriba , Adulto Joven
6.
Recenti Prog Med ; 96(1): 27-31, 2005 Jan.
Artículo en Italiano | MEDLINE | ID: mdl-15789635

RESUMEN

Non-organ specific autoantibodies are common in patients with chronic hepatitis C, making differential diagnosis difficult between viral, autoimmune forms and hepatitis C/autoimmune hepatitis overlap syndrome. The lack of additional criteria of autoimmunity in most patients leads to the definition of a "false" hepatitis C-autoimmune hepatitis overlap syndrome, while the "true" overlap syndrome occurs in a very few number of subjects. In patients with "false" overlap syndrome the first choice therapy is based on the administration of interferon plus ribavirin. On the contrary, first-line therapy with corticosteroids should be restricted to the "true" hepatitis overlap syndrome with the new therapeutic option of interferon/corticosteroid association.


Asunto(s)
Antiinflamatorios/uso terapéutico , Antivirales/uso terapéutico , Hepatitis C Crónica/diagnóstico , Hepatitis C Crónica/tratamiento farmacológico , Hepatitis Autoinmune/diagnóstico , Hepatitis Autoinmune/tratamiento farmacológico , Corticoesteroides/uso terapéutico , Diagnóstico Diferencial , Hepatitis C Crónica/complicaciones , Hepatitis Autoinmune/complicaciones , Humanos , Interferones/uso terapéutico , Ribavirina/uso terapéutico , Síndrome
7.
Recenti Prog Med ; 95(10): 472-5, 2004 Oct.
Artículo en Italiano | MEDLINE | ID: mdl-15560294

RESUMEN

The coexistence of non-organ specific autoantibodies and chronic hepatitis C features raises the dilemma as to whether the pathogenesis is viral or autoimmune and consequently to be treated with interferon or corticosteroids. Two cases with autoimmune characteristics and chronic hepatitis C are reported. We discuss the possibility of classifying this overlap form in three distinct entities: viral disease with an autoimmune epiphenomenon ("false hepatitis C/autoimmune hepatitis overlap syndrome"), viral disease associated to an autoimmune pathogenic component ("true hepatitis C/autoimmune hepatitis overlap syndrome") and false serological anti-HCV positivity in classical autoimmune hepatitis. In our experience the interferon/corticosteroid association was successful.


Asunto(s)
Hepatitis C Crónica/complicaciones , Hepatitis Autoinmune/complicaciones , Anciano , Antiinflamatorios/administración & dosificación , Antiinflamatorios/uso terapéutico , Antivirales/administración & dosificación , Antivirales/uso terapéutico , Quimioterapia Combinada , Femenino , Hepatitis C Crónica/diagnóstico , Hepatitis C Crónica/tratamiento farmacológico , Hepatitis Autoinmune/diagnóstico , Hepatitis Autoinmune/tratamiento farmacológico , Humanos , Interferones/administración & dosificación , Interferones/uso terapéutico , Persona de Mediana Edad , Prednisona/administración & dosificación , Prednisona/uso terapéutico , Factores de Tiempo
9.
Am J Hematol ; 72(1): 38-42, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12508267

RESUMEN

We describe a case of multiple myeloma (MM) presenting with high fever, inflammatory chemistry abnormalities, simultaneous acute renal failure, cholestatic hepatitis, and acute lung failure. The extremely aggressive course and pulmonary involvement in the form of pulmonary alveolar proteinosis (PAP) are discussed, stressing the unusual nature of the findings and the variable picture of MM.


Asunto(s)
Lesión Renal Aguda/etiología , Colestasis Intrahepática/etiología , Fiebre/etiología , Mieloma Múltiple/diagnóstico , Proteinosis Alveolar Pulmonar/etiología , Alanina Transaminasa/sangre , Fosfatasa Alcalina/sangre , Anemia Hipocrómica/etiología , Aspartato Aminotransferasas/sangre , Proteína C-Reactiva/análisis , Diagnóstico Diferencial , Resultado Fatal , Humanos , Infecciones/diagnóstico , L-Lactato Deshidrogenasa/sangre , Masculino , Persona de Mediana Edad , Mieloma Múltiple/sangre , Mieloma Múltiple/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...